Pathologic Fracture as Primary Presentation of Malignant Pheochromocytoma: A Case Report

  • Azar Fanipakdel Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Yasamin Davoudi 2 Department of Radiology, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Seyed Alireza Javadinia Student Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mahdi Silanian Toosi Mail Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Pheochromocytoma, Pathologic fracture, Initial presentation


Pheochromocytoma is a relatively rare tumor with no age preference. This tumor is usually diagnosed accidentally.  Pathologic fracture as the primary presentation of malignant pheochromocytoma is an uncommon presentation. The present case is a 23 year old man with malignant pheochromocytoma that his first chief complaint was bone pain due to pathological fracture. The presence of bone lesions as the first manifestation of pheochromocytoma makes this case a quite unusual one. 


Araki T, Chigusa I, Saitoh K. [A case of malignant ectopic pheochromocytoma with bone metastasis]. Hinyokika kiyo Acta urologica Japonica. 1989;35(6):1005-7. Epub 1989/06/01.

Cuerda C, Castejon I, Astigarraga B, Blanco C, Lucas T, Barcelo B, et al. [A malignant extra-adrenal pheochromocytoma. Apropos 2 cases]. Revista clinica espanola. 1993;192(2):76-8. Epub 1993/02/01. Feocromocitoma extraadrenal maligno. A proposito de dos casos.

Lynn MD, Braunstein EM, Wahl RL, Shapiro B, Gross MD, Rabbani R. Bone metastases in pheochromocytoma: comparative studies of efficacy of imaging. Radiology. 1986;160(3):701-6. Epub


Mukai M, Kanno N, Nakagawa M, Uemura M, Nishimura K, Miyoshi S, et al. [Malignant pheochromocytoma responsive to multimodal therapy: a case report]. Hinyokika kiyo Acta urologica Japonica. 2003;49(10):583-5. Epub 2003/12/06.

Okuyama A, Takahara S, Nakamura M, Oka T, Tada Y, Namiki M, et al. [Pheochromocytoma: review of 22 patients and 23 operations]. Hinyokika kiyo Acta urologica Japonica. 1987;33(10):1590-602. Epub 1987/10/01.

Yoshida S, Hatori M, Noshiro T, Kimura N, Kokubun S. Twenty-six-years' survival with multiple bone metastasis of malignant pheochromocytoma. Archives of orthopaedic and trauma surgery. 2001;121(10):598-600. Epub 2002/01/05.

Galifer RB, Pous JG, Noblet D. [Malignant pheochromocytoma. A case report in a 10-year-old boy with vertebral metastasis]. Chirurgie pediatrique. 1982;23(2):121-4. Epub 1982/03/01. Pheochromocytome et problemes de malignite. A propos d'un cas de pheochromocytome malin avec invasion vertebrale.

Kheir E, Pal D, Mohanlal P, Shivane A, Chakrabarty A, Timothy J. Cervical spine metastasis from adrenal pheochromocytoma. Acta neurochirurgica. 2006;148(11):1219-20. Epub 2006/09/23.

Krodel A, Lohscheidt K, Muller-Hocker J. [Surgical therapy of polytopic vertebral metastasis in malignant pheochromocytoma]. Zeitschrift fur Orthopadie und ihre Grenzgebiete. 1995;133(2):176-9. Epub 1995/03/01. Die operative Therapie einer polytopen Wirbelsaulenmetastasierung bei malignem Phaochromocytom.

Tan M, Camargo CA, Mojtahed A, Mihm F. Malignant pheochromocytoma presenting as incapacitating bony pain. Pain practice : the official journal of World Institute of Pain. 2012;12(4):286-9. Epub 2011/09/03.

Sun FK, He HC, Su TW, Zhou WL, Huang X, Dai J, et al. Multi-targeted tyrosine kinase inhibitor sunitinib: a novel strategy for sporadic malignant pheochromocytoma. Chinese medical journal. 2012;125(12):2231-4. Epub 2012/08/14.

Saito Y, Tanaka Y, Aita Y, Ishii KA, Ikeda T, Isobe K, et al. Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD. American journal of physiology Endocrinology and metabolism. 2012;302(6):E615-25. Epub 2011/09/01.

Parenti G, Zampetti B, Rapizzi E, Ercolino T, Giache V, Mannelli M. Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. Journal of oncology. 2012;2012:872713. Epub 2012/08/02.

Nemoto K, Miura T, Shioji G, Tsuboi N. Sunitinib treatment for refractory malignant pheochromocytoma. Neuro endocrinology letters. 2012;33(3):260-4. Epub 2012/05/29.

Nakano S, Tsushima Y, Higuchi T, Taketomi-Takahashi A, Amanuma M. Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma. Japanese journal of radiology. 2012;30(4):310-6. Epub 2012/01/25.

Maurea S, Cuocolo A, Imbriaco M, Pellegrino T, Fusari M, Cuocolo R, et al. Imaging characterization of benign and malignant pheochromocytoma or paraganglioma: comparison between MIBG uptake and MR signal intensity ratio. Annals of nuclear medicine. 2012;26(8):670-5. Epub 2012/07/04.

Fishbein L, Bonner L, Torigian DA, Nathanson KL, Cohen DL, Pryma D, et al. External beam radiation therapy (EBRT) for patients with malignant pheochromocytoma and non-head and -neck paraganglioma: combination with 131I-MIBG. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2012;44(5):405-10. Epub 2012/05/09.

Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocrine pathology. 2012;23(1):4-14. Epub 2011/12/20.

de Wailly P, Oragano L, Rade F, Beaulieu A, Arnault V, Levillain P, et al. Malignant pheochromocytoma: new malignancy criteria. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2012;397(2):239-46. Epub 2011/11/10.

Szalat A, Fraenkel M, Doviner V, Salmon A, Gross DJ. Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center. Endocrine. 2011;39(2):160-6. Epub 2010/11/12.

Park J, Song C, Park M, Yoo S, Park SJ, Hong S, et al. Predictive characteristics of malignant pheochromocytoma. Korean journal of urology. 2011;52(4):241-6. Epub 2011/05/11.

Harari A, Inabnet WB, 3rd. Malignant pheochromocytoma: a review. American journal of surgery. 2011;201(5):700-8. Epub 2010/09/28.

Feng F, Zhu Y, Wang X, Wu Y, Zhou W, Jin X, et al. Predictive factors for malignant pheochromocytoma: analysis of 136 patients. The Journal of urology. 2011;185(5):1583-90. Epub 2011/03/23.

How to Cite
Fanipakdel A, Davoudi Y, Javadinia SA, Silanian Toosi M. Pathologic Fracture as Primary Presentation of Malignant Pheochromocytoma: A Case Report. Acta Med Iran. 56(12):803-806.
Case Report(s)